Evidence map›Paper›PMID 34197751›Full record

ArticleThe Lancet. Oncology2021

Second-line FOLFOX chemotherapy for advanced biliary tract cancer - Authors' reply.

Angela Lamarca, Daniel H Palmer, Harpreet Singh Wasan, Paul J Ross, Yuk Ting Ma, Arvind Arora, Stephen Falk, Roopinder Gillmore, Jonathan Wadsley, Kinnari Patel and 12 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The Lancet. Oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Angela LamarcaDepartment of Medical Oncology, The Christie NHS Foundation Trust/Institute of Cancer Sciences, University of Manchester, Manchester M20 4BX,, UK.
Daniel H PalmerUniversity of Liverpool and Clatterbridge Cancer Centre, Liverpool, UK.
Harpreet Singh WasanDepartment of Cancer Medicine, Hammersmith Hospital, Imperial Colllege London, London, UK.
Paul J RossGuy's Cancer, Guy's & St Thomas' NHS Foundation Trust, London, UK.
Yuk Ting MaDepartment of Hepatobiliary Oncology, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Arvind AroraDepartment of Medical Oncology, University Hospital of Nottingham NHS Trust, University of Nottingham, Nottingham, UK.
Stephen FalkBristol Haematology and Oncology Centre, Bristol, UK.
Roopinder GillmoreDepartment of Medical Oncology, Royal Free NHS Foundation Trust, London, UK.
Jonathan WadsleyWeston Park Cancer Centre, Sheffield, UK.
Kinnari PatelDepartment of Medical Oncology, Cancer and Haematology Centre, Oxford, UK.
Alan AnthoneyDepartment of Medical Oncology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Anthony MaraveyasDepartment of Medical Oncology, Hull University Teaching Hospitals NHS Trust, Hull, UK.
Tim IvesonDepartment of Gastro- Intestinal Oncology, University Hospital Southampton NHS Foundation Trust, Southampton University, Southampton, UK.
Justin S WatersKent Oncology Centre, Maidstone, UK.
Claire HobbsDepartment of Clinical Oncology, Great Western Hospital, Swindon, UK.
Safia BarberManchester Clinical Trials Unit, University of Manchester, Manchester M20 4BX, UK.
W David RyderManchester Clinical Trials Unit, University of Manchester, Manchester M20 4BX, UK.
John RamageHampshire Hospitals NHS Foundation Trust, Basingstoke, UK.
Linda M DaviesManchester Centre for Health Economics, University of Manchester, Manchester M20 4BX, UK.
John A BridgewaterUCL Cancer Institute, University College London, London, UK.
Juan W ValleDepartment of Medical Oncology, The Christie NHS Foundation Trust/Institute of Cancer Sciences, University of Manchester, Manchester M20 4BX,, UK; Division of Cancer Sciences, University of Manchester, Manchester M20 4BX, UK. Electronic address: juan.valle@manchester.ac.uk.
Advanced Biliary Cancer Working Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bile Duct NeoplasmsBiliary Tract NeoplasmsHumansLeucovorinLeucovorin

Identifiers

PMID34197751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.